Cutting-edge technology, Australian made

Cylite’s Hyperparallel-OCT™ is featured in the latest edition of the ODMA eyetalk Equipment Magazine 2023. Learn more about the HP-OCT™ difference and see examples of eye images produced by this revolutionary device in the article below.

How Hyperparallel technology is transforming clinical research

With its ability to overcome constraints related to eye motion artefacts, its true volumetric imaging capabilities, and its micron-level accuracy, HP-OCTTM is clearing the way for important new research opportunities in eye health and beyond. As the first of its kind in the world, HP-OCTTM is an exciting next generation technology that has the opportunity … Continued

Cylite embarks on crucial scale up

The transition into production and sales is proving a pivotal moment for Cylite, as we embark on a crucial scale-up to bring our technology to the world. We were grateful to be featured in Insight July 2022, in which the team took a look at Cylite’s growth and scale up activities.

New Cylite CEO eyes off the $4.8 billion global eyecare industry

Kylee Hall, a proven leader in the Australasian Ophthalmic Industry, has taken over as Cylite’s CEO from renowned scientist Dr Steve Frisken. Ms Hall brings a stellar industry career in delivering products into the medical and ophthalmic markets. Dr Frisken will continue in an executive leadership role to provide operational and innovation guidance to the … Continued

Cylite supporting Australian business

Two Australian companies working together to create beautifully crafted products.  Milton Ashby have worked with the team at Cylite to create a bespoke accessories box from sustainable materials for the HP-OCT™.  For Milton Ashby outsourcing the manufacturing didn’t make sense either, their products are made in Australia just like the HP-OCT™. For more details on … Continued


This website is intended for use by healthcare professionals only. By clicking agree, you are declaring that you are a registered healthcare professional with an appropriate registration.

If you do not agree, you’ll not be able to view the content on this page.